Lenvatinib Suppresses Protein Kinase B Signaling and Induces Apoptosis in Osteosarcoma Cells
Anticancer Research · 2024
DOI: 10.21873/anticanres.16790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Chun-Yi Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.
- Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
- Department of Radiation Oncology, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.
- Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C.
- Department of Surgery, Zuoying Armed Forces General Hospital, Kaohsiung, Taiwan, R.O.C.
- Department of Surgery, National Defense Medical Center, Taipei, Taiwan, R.O.C.
Zitieren
APA
Li, C. Y., Chen, H. C., Liao, C. Y., Hsu, F. T., Hung, K. C., Liu, K. C., Chen, J. C., & Ku, M. C. (2024). Lenvatinib Suppresses Protein Kinase B Signaling and Induces Apoptosis in Osteosarcoma Cells. Anticancer Research. https://doi.org/10.21873/anticanres.16790
Vancouver
Li CY, Chen HC, Liao CY, Hsu FT, Hung KC, Liu KC, et al. Lenvatinib Suppresses Protein Kinase B Signaling and Induces Apoptosis in Osteosarcoma Cells. Anticancer Research. 2024. doi:10.21873/anticanres.16790
BibTeX
@article{Li2024,
author = {Li, Chun-Yi and Chen, Hsin-Chuan and Liao, Chih-Ying and Hsu, Fei-Ting and Hung, Kuang-Chen and Liu, Kuo-Ching and Chen, Jaw-Chyun and Ku, Ming-Chou},
title = {Lenvatinib Suppresses Protein Kinase B Signaling and Induces Apoptosis in Osteosarcoma Cells},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16790}
}
EUVIMED